Delivery robot developer Pudu Robotics received a series B investment by the mobile services platform in connection with a strategic partnership.
Month: July 2020
From virus to bacteria for funding
It is worth remembering the coronavirus and its related covid-19 disease is bad but far from a worse-case scenario.
Palantir proclaims confidential listing preparation
The Sompo, Relx and Fujitsu-backed big data analytics provider, valued at more than $20bn in 2015, has revealed it has confidentially filed for a public listing.
Immatics completes $253m reverse merger
Amgen-backed immuno-oncology spinout Immatics has gone public through a reverse merger with special purpose acquisition company Arya Sciences.
Nkarta endeavours to raise $160m in IPO
Novo, GSK and Amgen-backed NK oncology therapy developer Nkarta Therapeutics has set a range that will net it between $140m and $160m.
Nurix picks Nasdaq for $100m IPO filing
Celgene is set for an exit having invested $17m in small molecule cancer drug developer Nurix Therapeutics five years ago.
Inozyme ignites IPO proceedings
Novo and Sanofi are among the investors that could exit the mineralisation disease therapy developer, which has filed to raise up to $86.3m.
Mission Therapeutics meets $15m objective
Pfizer Ventures joined Mission’s other existing investors to push the mitochondria-focused drug developer’s lifetime funding to approximately $143m.
Zongteng zeroes in on series C1 funding
The GLP-backed international logistics provider raised $71.1m in a Taikang-led round that will support a global expansion.
Payfazz picks up $53m series B
BRI Ventures was part of a consortium that provided $53m for mobile wallet developer Payfazz, which also counts Telkom Indonesia as an investor.
Redding relocates from Accenture Ventures
Accenture Ventures founder Michael Redding is leaving its parent company – consulting firm Accenture – after almost 30 years.
Social Bella rings up $58m
The iStyle and EV Growth-backed beauty e-commerce and media company has raised upwards of $110m altogether, having just captured series E funding.
Steen swings from Syngenta to Legacy Seed
Colin Steen, one of Syngenta Ventures’ managing directors, has departed from the unit after more than two years for a chief executive role elsewhere.
Kiba promoted to head UMI
United Materials Incubator, whcich counts a range of corporates as limited partners, has promoted partner Shosuke Kiba to a managing partner position.